Chloroplasts as expression platforms for plant-produced vaccines
Authors:
- Teodoro CardiTCTeodoro Cardi
- Paolo LenziPLPaolo Lenzi
- Pal MaligaPMPal Maliga
- 1 August 2010
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Vaccines
- Vol. 9 (8) , 893-911
Abstract
Production of recombinant subunit vaccines from genes incorporated in the plastid genome is advantageous because of the attainable expression level due to high transgene copy number and the absence of gene silencing; biocontainment as a consequence of maternal inheritance of plastids and no transgene presence in the pollen; and expression of multiple transgenes in prokaryotic-like operons. We discuss the core technology of plastid transformation in Chlamydomonas reinhardtii, a unicellular alga, and Nicotiana tabacum (tobacco), a flowering plant species, and demonstrate the utility of the technology for the production of recombinant vaccine antigens.Keywords
This publication has 171 references indexed in Scilit:
- Tobacco, a highly efficient green bioreactor for production of therapeutic proteinsBiotechnology Advances, 2010
- Plant-made vaccine antigens and biopharmaceuticalsTrends in Plant Science, 2009
- Spontaneous capture of oilseed rape (Brassica napus) chloroplasts by wild B. rapa: implications for the use of chloroplast transformation for biocontainmentCurrent Genetics, 2009
- Plant-produced vaccines: promise and realityDrug Discovery Today, 2009
- HPV Vaccines: Today and in the FutureJournal of Adolescent Health, 2008
- Determining the transgene containment level provided by chloroplast transformationProceedings of the National Academy of Sciences, 2007
- Production of vaccines and therapeutic antibodies for veterinary applications in transgenic plants: an overviewTransgenic Research, 2007
- Pharma-Planta: road testing the developing regulatory guidelines for plant-made pharmaceuticalsTransgenic Research, 2007
- Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectorsProceedings of the National Academy of Sciences, 2006
- Molecular farming for new drugs and vaccinesEMBO Reports, 2005